Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Second-site NMR screening and linker design.

Wolfgang Jahnke1, Andreas Flörsheimer, Marcel J J Blommers

  • 1Novartis Pharma AG, Central Technologies and Oncology Research, CH-4002 Basel, Switzerland. wolfgang.jahnke@pharma.novartis.com

Current Topics in Medicinal Chemistry
|February 7, 2003
PubMed
Summary

Nuclear Magnetic Resonance (NMR) enables sensitive detection of weak protein-ligand interactions for drug discovery. This review details methods for fragment-based drug design using NMR to link ligands for high-affinity drug candidates.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: Dynamic conformational equilibria in the active states of KRAS and NRAS.

RSC chemical biology·2026
Same author

Correction to "Fragment-to-Lead Medicinal Chemistry Publications in 2024: A Tenth Annual Perspective".

Journal of medicinal chemistry·2026
Same author

Fragment-based discovery enables direct targeting of the melanoma oncogene MITF.

Nature communications·2025
Same author

Identification and characterization of binders to a cryptic and functional pocket in KRAS.

Nature communications·2025
Same author

Fragment-to-Lead Medicinal Chemistry Publications in 2024: A Tenth Annual Perspective.

Journal of medicinal chemistry·2025
Same author

Targeting the SARS-CoV-2 RNA Translation Initiation Element SL1 by Molecules of Low Molecular Weight.

Journal of the American Chemical Society·2025

Area of Science:

  • Biochemistry
  • Medicinal Chemistry
  • Structural Biology

Background:

  • Nuclear Magnetic Resonance (NMR) spectroscopy is a powerful technique for characterizing molecular interactions.
  • Detecting weak protein-ligand interactions is crucial for early-stage drug discovery.
  • Fragment-based drug design (FBDD) offers a modular approach to building high-affinity ligands.

Purpose of the Study:

  • To review methods for identifying "second-site" ligands in the presence of a bound "first-site" ligand using NMR.
  • To discuss techniques for determining the spatial orientation of multiple ligands on a protein target.
  • To provide a framework for rational chemical linkage of fragments based on structural information.

Main Methods:

  • NMR-based screening for secondary binding events.

Related Experiment Videos

  • Structural elucidation of ligand-protein complexes using NMR.
  • Fragment linking strategies informed by structural data.

    • Main Results:

    • NMR's sensitivity and robustness are key for detecting weak interactions in FBDD.
    • Methods allow for the identification and structural characterization of adjacent binding ligands.
    • Successful application of second-site screening and linker design is demonstrated through examples.

    Conclusions:

    • NMR facilitates fragment-based drug discovery by enabling the detection and structural characterization of weak protein-ligand interactions.
    • The described methods support the rational design of high-affinity ligands through chemical linkage of identified fragments.
    • This approach enhances the efficiency of lead optimization in drug discovery research.